Frank LÖSCHER
18Patents
5h-index
13Co-inventors
59Inventor score
Filing activity: Apr 12, 2006 → Jun 6, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10682315B2 | Semifluorinated compounds and their compositions | Human Necessities | 15 | Active |
| US10813976B2 | Ophthalmic compositions comprising ciclosporin | Human Necessities | 15 | Active |
| US11154513B2 | Semifluorinated compounds | Chemistry; Metallurgy | 15 | Active |
| US11273174B2 | Iodine compositions | Emerging Cross-Sectional Technologies | 11 | Active |
| US11357738B2 | Semifluorinated compounds and their compositions | Human Necessities | 9 | Active |
| US11576893B2 | Pharmaceutical compositions comprising nebivolol | Human Necessities | 4 | Active |
| US11684589B2 | Pharmaceutical compositions for use in the therapy of blepharitis | Emerging Cross-Sectional Technologies | 3 | Active |
| US11723861B2 | Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases | Human Necessities | 3 | Active |
| US7398704B2 | Sensor assembly and method of assembling a sensor module in a transmission | Physics | 3 | Active |
| US11896559B2 | Opthalmic compositions comprising F6H8 | Human Necessities | 3 | Active |
| US11400132B2 | Ophthalmic compositions comprising ciclosporin | Human Necessities | 3 | Active |
| US12029757B2 | Lipid barrier repair | Human Necessities | 2 | Active |
| US11510855B2 | Topical sunscreen formulation | Human Necessities | 2 | Active |
| US12150955B2 | Iodine compositions | Emerging Cross-Sectional Technologies | 2 | Active |
| US12226422B2 | Ophthalmic compositions comprising tafluprost for the treatment of glaucoma | Human Necessities | 2 | Active |
| US12128010B2 | Semifluorinated compounds and their compositions | Human Necessities | 2 | Active |
| US12419933B2 | Ophthalmic composition for the treatment of uveitis | Human Necessities | 0 | Active |
| US8087146B2 | Transmission clutch assembly fixture | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.